ScoreWhy is Dr Lal Pathlabs Ltd ?
1
High Management Efficiency with a high ROE of 20.98%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 14.39% and Operating profit at 19.92% over the last 5 years
4
The company has declared Positive results for the last 3 consecutive quarters
- PAT(9M) At Rs 437.60 cr has Grown at 36.71%
- NET SALES(Q) Highest at Rs 730.60 cr
- PBDIT(Q) Highest at Rs 224.10 cr.
5
With ROE of 22.4, it has a Very Expensive valuation with a 10.5 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 1.40%, its profits have risen by 33.1% ; the PEG ratio of the company is 1.4
6
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -0.58% over the previous quarter and currently hold 53.21% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Dr Lal Pathlabs should be less than 10%
- Overall Portfolio exposure to Healthcare Services should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Dr Lal Pathlabs for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Dr Lal Pathlabs
13.77%
0.05
27.42%
Sensex
-5.12%
0.44
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.81%
EBIT Growth (5y)
11.57%
EBIT to Interest (avg)
18.38
Debt to EBITDA (avg)
0.44
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
1.08
Tax Ratio
23.81%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
38.57%
ROCE (avg)
53.14%
ROE (avg)
20.01%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
52
Industry P/E
60
Price to Book Value
10.99
EV to EBIT
42.60
EV to EBITDA
33.79
EV to Capital Employed
19.23
EV to Sales
9.57
PEG Ratio
6.64
Dividend Yield
0.61%
ROCE (Latest)
45.14%
ROE (Latest)
21.01%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-4What is not working for the Company
PAT(Q)
At Rs 131.30 cr has Fallen at -15.2%
DEBTORS TURNOVER RATIO(HY)
Lowest at 24.96 times
Loading Valuation Snapshot...
Here's what is not working for Dr Lal Pathlabs
Profit After Tax (PAT) - Quarterly
At Rs 131.30 cr has Fallen at -15.2%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Debtors Turnover Ratio- Half Yearly
Lowest at 24.96 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
